Advertisement

Topics

Latest "Aflac Cancer Center" News Stories

00:11 EDT 24th October 2017 | BioPortfolio

Here are the most relevant search results for "Aflac Cancer Center" found in our extensive news archives from over 250 global news sources.

More Information about Aflac Cancer Center on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Aflac Cancer Center for you to read. Along with our medical data and news we also list Aflac Cancer Center Clinical Trials, which are updated daily. BioPortfolio also has a large database of Aflac Cancer Center Companies for you to search.

Showing "Aflac Cancer Center" News Articles 1–25 of 18,000+

Extremely Relevant

Aflac has Donated More Than $118 Million to Childhood Cancer

Did you know Aflac entered the childhood cancer community 22 years ago? SOURCE: Aflac DESCRIPTION:Aflac donated $3 million to sponsor the Aflac Cancer & Blood Disorders Center at what is now known as Children's Healthcare of Atlanta. To date, Aflac has d


Aflac was #ThereWhen | The Hollist Family

SOURCE: Aflac DESCRIPTION: When Aflac employee and policyholder Japen Hollist’s son, P.K., was hospitalized following a life-threatening injury, Aflac was #ThereWhen they needed it most. Learn more about Aflac's Duckprints in the Workplace    

This Duck Goes Gold for Kids With Cancer

SOURCE: Aflac DESCRIPTION:September is Childhood Cancer Awareness Month. More than 20 years ago, Aflac adopted the charge to further childhood cancer research and treatment and to support families in that struggle. This month, we are “going gold” alongside the childhood cancer community to continue to help raise awareness and funds for these kids. Join the conversation on Facebook  Tweet me:...


The Aflac Childhood Cancer Campaign

Give the gift that gives back SOURCE: Aflac DESCRIPTION:Give the gift that gives back – because you shouldn’t have to choose between looking good and doing good. 100% of all net proceeds from #Duckprints merchandise will go to hospitals treating childhood cancer across the United States. Visit the Duckprints store now    Tweet me: Give the gift that gives back with @A

Aflac #Duckprints

It takes one person to make a difference, but an army to find a cure. SOURCE: Aflac DESCRIPTION:Help fight pediatric cancer by using #Duckprints on social media, and for every mention, Aflac will donate $2 – up to $1.5 million – towards fighting childhood cancer.  Learn more about how you can add your #Duckprints here   Tweet me:

Aflac Sponsors National Discussion on Childhood Cancer in Washington DC

WASHINGTON, Sept. 15, 2017 /PRNewswire/ -- Aflac, the leading provider of voluntary insurance sales at the worksite in the U.S. and a committed corporate ally in the fight against childhood cancer, today sponsored Children & Cancer, a national discussion on childhood cancer along with Atlantic Media at the Newseum in Washington D.C. The event included a touching conversation between...

Relevant

Aflac Expands 22-Year Commitment to Childhood Cancer With New Aflac Childhood Cancer Campaign™

COLUMBUS, Ga., Sept. 8, 2017 /PRNewswire/ -- In honor of Childhood Cancer Awareness Month in September, Aflac, the leader in voluntary insurance sales at the worksite in the U.S. and longtime champion of the childhood cancer cause, today announced the launch of the Aflac Childhood Cancer Campaign. The program aims to provide innovative care and support for the nearly 16,000 children newly dia...

Aflac Serves as Diamond Sponsor at CureFest for Childhood Cancer Awareness Month

COLUMBUS, Ga., Sept. 14, 2017 /PRNewswire/ -- Aflac, the leading provider of voluntary insurance sales at the worksite in the U.S. and a longtime champion of the childhood cancer cause, today announced that it will once again sponsor CureFest. A grassroots event, CureFest aims to make childhood cancer research a national priority by uniting the childhood cancer community, the general public, ...

Aflac Lands at No. 23 in LATINA Style's List of 50 Best Companies for Latinas to Work

ATLANTA, Sept. 21, 2017 /PRNewswire/ -- Aflac, the leading provider of voluntary insurance sales at the worksite today announced that the company has once again landed a coveted spot on LATINA Style's list of 50 Best Companies for Latinas to Work for in the United States. This makes the 18th time that Aflac has appeared on this list. According to LATINA Style, the annual LATINA Style 50 Report is ...

Hyundai Hope On Wheels to Award $400,000 in Research Grants to the Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta in Honor of National Childhood Cancer Awareness Month

ATLANTA, Sept. 5, 2017 /PRNewswire/ -- Hyundai Hope On Wheels® will present the Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta with awards totaling  $400,000 for the Hyundai Scholar Hope and Young Investigator Grants. The grant funds will support the research of principal investigators Dr. Sunil S. Raikar and Dr. Christopher C. Porter, respectively. Thi...

GIST tumours linked to NF1 mutations, genetic testing needed

Researchers at UC San Diego Moores Cancer Center, with colleagues from Memorial Sloan Kettering Cancer Center and Fox Chase Cancer Center, have determined that a specific region of the small bowel, called the duodenal-jejunal flexure or DJF, shows a high...

UT Health Cancer Center Hires Rare Blood Cancer Expert as Director

San Antonio — The University of Texas Health Science Center at San Antonio has hired a new director for its UT Health Cancer Center: Ruben Mesa, a researcher who has lengthy experience testing treatments for rare blood cancers. Mesa is joining the UT from the Mayo Clinic Cancer Center in Arizona, where he was deputy director. […]

Successful treatment for advanced stage testicular cancer in down syndrome patients

(St. Joseph's Hospital and Medical Center) Research by Jue Wang, MD, at the University of Arizona Cancer Center at Dignity Health St. Joseph's Hospital and Medical Center on 'Delay in Diagnosis of Testicular Cancer in a Patient with Down Syndrome' was published in the October issue of Journal of Cancer and Therapeutic Science.

Moffitt researchers identify inhibitor that overcomes drug resistance in prostate cancer

(H. Lee Moffitt Cancer Center & Research Institute) In a study published today in Cancer Cell, Moffitt Cancer Center researchers report that a newly discovered epigenetic mechanism can lead to the development of castration-resistant prostate cancer.

Good-guy bacteria may help cancer immunotherapies do their job

(UT Southwestern Medical Center) Individuals with certain types of bacteria in their gut may be more likely to respond well to cancer immunotherapy, researchers at the Harold C. Simmons Comprehensive Cancer Center found in a study of patients with metastatic melanoma.

Research aims to raise awareness of higher rate of testicular cancer in patients with DS

Research by Jue Wang, MD, at the University of Arizona Cancer Center at Dignity Health St. Joseph's Hospital and Medical Center on "Delay in Diagnosis of Testicular Cancer in a Patient with Down Syndrome" was published in the October issue of Journal of Cancer and Therapeutic Science.

Effect of treatment trials on survival of patients with cancer in US population

(The JAMA Network Journals) Joseph M. Unger, Ph.D., M.S., of the SWOG Statistical Center and the Fred Hutchinson Cancer Research Center, Seattle, Wash., and coauthors examined how the National Cancer Institute-sponsored network of cooperative cancer research groups has benefited patients with cancer in the general population.

GIST tumors linked to NF1 mutations, genetic testing needed

(University of California - San Diego) Researchers at UC San Diego Moores Cancer Center, with colleagues from Memorial Sloan Kettering Cancer Center and Fox Chase Cancer Center, have determined that a specific region of the small bowel, called the duodenal-jejunal flexure or DJF, shows a high frequency of gastrointestinal stromal tumors (GISTs) with mutations of the NF1 gene.

Genetic targets to chemo-resistant breast cancer identified

(UT Southwestern Medical Center) Research led by Dr. Carlos Arteaga, Director of the Harold C. Simmons Comprehensive Cancer Center, has identified potential targets for treatment of triple negative breast cancer, the most aggressive form of breast cancer.

Breakthrough cancer treatment brings hope and challenges

(The Hastings Center) The first gene therapy for cancer will transform approaches to cancer treatments, but it poses ethical challenges for policy-makers, as described by three Hastings Center scholars in the October issue of Health Affairs.

Experimental drug co-developed by Moffitt Cancer Center researcher shows promise

(H. Lee Moffitt Cancer Center & Research Institute) The investigation found that the drug, geranylgeranyltransferase inhibitor GGTI-2418 suppresses a new defective PTEN cancer pathway discovered by Pagano's group.

UA Cancer Center team identifies a switch that may help target dormant cancer cells

(University of Arizona Health Sciences) Cells can enter a dormant state called quiescence, and dormant cancer cells are resistant to chemotherapy and other treatments. A team led by UA Cancer Center researcher Guang Yao, Ph.D., has identified ways to regulate cell dormancy and 'wake' these cells from their 'slumber' to make them susceptible to cancer treatments.

Reducing disparities in cancer precision medicine

(Louisiana State University Health Sciences Center) The National Cancer Institute has awarded LSU Health New Orleans and Moffitt Comprehensive Cancer Center in Tampa a $2 million grant over four years to study cancer precision medicine with an emphasis on underserved minorities and to train students and junior scientists in cancer health disparities-based precision medicine research.

First-in-class drug holds promise for therapy-resistant breast cancer

(UT Southwestern Medical Center) UT Southwestern Simmons Cancer Center researchers have shown that a first-in-class molecule can prevent breast cancer growth when traditional therapies stop working.

Study finds 75 percent of depressed cancer center patients were previously undiagnosed

(American Society for Radiation Oncology) A new study of patients at an urban cancer center points to a potentially serious problem that may limit the impact of clinical cancer care -- undiagnosed depression.


Quick Search
Advertisement
 

News Quicklinks